The TLL conducts scientific exchange, gathers clinical insights, identifies speakers and advisors, and collaborates with cross-functional teams including KAMs, CSs, MSLs, Marketing, and Medical Affairs. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.